======= GGCX ======= == Gene Information == * **Official Symbol**: GGCX * **Official Name**: gamma-glutamyl carboxylase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2677|2677]] * **UniProt**: [[https://www.uniprot.org/uniprot/P38435|P38435]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GGCX&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GGCX|Open PubMed]] * **OMIM**: [[https://omim.org/entry/137167|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]. * **UniProt Summary**: Mediates the vitamin K-dependent carboxylation of glutamate residues to calcium-binding gamma-carboxyglutamate (Gla) residues with the concomitant conversion of the reduced hydroquinone form of vitamin K to vitamin K epoxide. {ECO:0000269|PubMed:17073445}. |VKG Carbox| |gamma-glutamyl carboxylase activity| |peptidyl-glutamic acid carboxylation| |protein carboxylation| |peptidyl-glutamic acid modification| |blood coagulation| |coagulation| |hemostasis| |wound healing| |regulation of body fluid levels| |response to wounding| |peptidyl-amino acid modification| |endoplasmic reticulum membrane| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-2.22| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.92| |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.71| |[[:results:exp515|PU-H71 1μM R08 exp515]]|1.77| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|1.82| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|2.13| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.497| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16216 * **Expression level (log2 read counts)**: 6.64 {{:chemogenomics:nalm6 dist.png?nolink |}}